These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 5401598)

  • 41. Effect of somatostatin and bombesin on secretin-stimulated ductular bile flow in dogs.
    Kaminski DL; Deshpande YG
    Gastroenterology; 1983 Dec; 85(6):1239-47. PubMed ID: 6138292
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Study of the exocrine function of the human pancreas, using continuous perfusionsof secretin. II. Influence of increasing doses on lipase output in basal conditions and after injection of pancreozymin].
    Ribet A; Pascal JP; Sannou N
    Arch Fr Mal App Dig; 1967; 56(7):685-90. PubMed ID: 5618241
    [No Abstract]   [Full Text] [Related]  

  • 43. Immunoglobulin concentrations in the duodenal fluids of infants and children. II. The effect of pancreozymin and secretin.
    Lebenthal E; Clark B
    Am J Gastroenterol; 1981 Jun; 75(6):436-9. PubMed ID: 7270539
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced bile flow associated with parenteral nutrition is independent of oxidant load and parenteral multivitamins.
    Lavoie JC; Chessex P; Gauthier C; Levy E; Alvarez F; St-Louis P; Rouleau T
    J Pediatr Gastroenterol Nutr; 2005 Jul; 41(1):108-14. PubMed ID: 15990639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic and hemodynamic effects of secretin and pancreozymin on the pancreas.
    Frogge JD; Hermreck AS; Thal AP
    Surgery; 1970 Sep; 68(3):498-502. PubMed ID: 5460522
    [No Abstract]   [Full Text] [Related]  

  • 46. Sodium, hydrogen exchange type 1 and bile ductular secretory activity in the guinea pig.
    Hübner C; Stremmel W; Elsing C
    Hepatology; 2000 Mar; 31(3):562-71. PubMed ID: 10706543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Secretin and cholestasis, two sides of a coin.
    Wagner M; Fickert P; Zollner G
    Hepatology; 2016 Sep; 64(3):714-6. PubMed ID: 27312229
    [No Abstract]   [Full Text] [Related]  

  • 48. Secretin and cholecystokinin-pancreozymin in combination in the inhibition of gastric acid secretion.
    Bedi BS; Gillespie G; Gillespie IE
    Br J Surg; 1969 May; 56(5):384-5. PubMed ID: 5781070
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of dihydroxydibutylether (DHBE) on bile flow and composition in rats with ethynylestradiol-induced cholestasis.
    Podda M; Zuin M; Dioguardi ML; Festorazzi S; Di Padova C
    Arzneimittelforschung; 1980; 30(12):2126-8. PubMed ID: 7194073
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of effects of gastrin, cholecystokinin-pancreozymin, secretin, and glucagon on human stomach muscle in vitro.
    Cameron AJ; Phillips SF; Summerskill WH
    Gastroenterology; 1970 Oct; 59(4):539-45. PubMed ID: 5477749
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of curcumin on cyclosporine-induced cholestasis and hypercholesterolemia and on cyclosporine metabolism in the rat.
    Deters M; Klabunde T; Meyer H; Resch K; Kaever V
    Planta Med; 2003 Apr; 69(4):337-43. PubMed ID: 12709901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Origin and mode of action of cholecystokinin--pancreozymin].
    Jorpes JE
    Verh Dtsch Ges Inn Med; 1969; 75():292-6. PubMed ID: 5400136
    [No Abstract]   [Full Text] [Related]  

  • 53. THE EFFECT OF SECRETIN ON BILE FLOW.
    JORPES JE; MUTT V; JONSON G; THUL ; SUNDMANLIN L
    Gastroenterology; 1963 Dec; 45():786-8. PubMed ID: 14134013
    [No Abstract]   [Full Text] [Related]  

  • 54. A novel role for interleukin 32 in cholestasis.
    Zhang X; Li L; Zhao N; Pan Q; Zhang L; Xie Q; Li X; Liao M; Li Q; Huang X; Chen S; Li J; Wang H; Huang X; Fan S; Wang Y; Li M; Chai J
    Clin Transl Med; 2021 Nov; 11(11):e594. PubMed ID: 34841712
    [No Abstract]   [Full Text] [Related]  

  • 55. 50 Years Ago in TheJournalofPediatrics: Medical Therapies for Pediatric Cholestasis.
    Pandurangi S
    J Pediatr; 2022 Jul; 246():198. PubMed ID: 35750390
    [No Abstract]   [Full Text] [Related]  

  • 56. The flow and ionic composition of bile.
    WHEELER HO
    Arch Intern Med; 1961 Jul; 108():156-62. PubMed ID: 13784761
    [No Abstract]   [Full Text] [Related]  

  • 57. Determinants of the flow and composition of bile.
    WHEELER HO
    Gastroenterology; 1961 Apr; 40():584-6. PubMed ID: 13784760
    [No Abstract]   [Full Text] [Related]  

  • 58. [Influence of secretin and pancreozymin on bile flow and bile composition in patients with and without cholestasis].
    Bode C; Goebell H; Löber D; Dölle W
    Verh Dtsch Ges Inn Med; 1969; 75():640-2. PubMed ID: 5401598
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of secretin and pancreozymin on choleresis in patients with and without choleastasis (author's transl)].
    Bode C; Löber D; Goebell H; Dölle W; Körner K
    Acta Hepatogastroenterol (Stuttg); 1972; 19(6):440-50. PubMed ID: 4667935
    [No Abstract]   [Full Text] [Related]  

  • 60. Influence of secretin and cholecystokinin on intestinal alkaline phosphatase secretion.
    Dyck WP; Martin GA; Ratliff CR
    Gastroenterology; 1973 Apr; 64(4):599-602. PubMed ID: 4700774
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.